Skip to main content
OpenTrials

Clinical trial condition

Severe Hypertriglyceridemia

Explore clinical trials studying Severe Hypertriglyceridemia. Study availability and eligibility vary by location and protocol.

20 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Severe Hypertriglyceridemia trial results

Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

NCT06880770

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site Los Angeles, California, United States
  • Clinical Research Site 4 Santa Clarita, California, United States
  • Research Site New Haven, Connecticut, United States
  • Clinical Research Site 6 Springfield, Illinois, United States
View all 102 locations
View Trial Details
Recruiting

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

NCT07269210

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Axsendo Clinical Research - Peak Heart & Vascular - Phoenix Phoenix, Arizona, United States
  • Synexus Clinical Research US, Inc./Orange Grove Family Practice Tucson, Arizona, United States
  • National Heart Institute Beverly Hills, California, United States
  • Ark Clinical Research Long Beach, California, United States
View all 41 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability and Efficacy of ION775

NCT07604974

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Ionis Investigative Site Lincoln, California, United States
  • Ionis Investigative Site Aurora, Colorado, United States
  • Ionis Investigative Site Boca Raton, Florida, United States
  • Ionis Investigative Site Miami, Florida, United States
View all 16 locations
View Trial Details
Completed

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

NCT05852431

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Peoria, Arizona, United States
  • 89Bio Clinical Study Site Tucson, Arizona, United States
  • 89bio Clinical Study Site Conway, Arkansas, United States
View all 177 locations
View Trial Details
Completed

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

NCT05355402

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
Locations
  • Clinical Trials Research Lincoln, California, United States
  • Catalina Research Institute, LLC Montclair, California, United States
  • Excel Medical Clinical Trials, LLC Boca Raton, Florida, United States
  • De La Cruz Research Center Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

NCT04720534

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site 2 Beverly Hills, California, United States
  • Research Site 4 Palm Springs, California, United States
  • Research Site 5 Boca Raton, Florida, United States
  • Research Site 6 Fort Lauderdale, Florida, United States
View all 74 locations
View Trial Details
Completed

A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

NCT05079919

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Accel Research Sites Network Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Velocity Clinical Research Chula Vista, California, United States
  • Diabetes/Lipid Management & Research Center Huntington Beach, California, United States
View all 209 locations
View Trial Details
Completed

A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

NCT06555640

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Baoding No.1 Central Hospital Baoding, China
  • The First Affiliated Hospital of Baotou Medical College Baotou, China
  • Peking University First Hospital Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 35 locations
View Trial Details
Completed

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

NCT05552326

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Alabama Clinical Therapeutics, LLC Alabaster Birmingham, Alabama, United States
  • Onyx Clinical Research Peoria, Arizona, United States
  • NRC Research Institute Los Angeles, California, United States
View all 205 locations
View Trial Details

Related conditions